Concepedia

Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

Ray Y. Chen, Laura E. Via, Lori E. Dodd, Gerhard Walzl, Stephanus T. Malherbe, André G. Loxton, Rodney Dawson, Robert J. Wilkinson, Friedrich Thienemann, Michèle Tameris,

Gates Open Research · 2017 · 42 citations · 31 references

DOIFull text

Open access

Abstract

NCT02821832.

References

31

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

Catharina Boehme, Pamela Nabeta, Doris Hillemann et al. · New England Journal of Medicine · 2010 · 2.3K citations · Full text

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

Stephen H. Gillespie, Angela M. Crook, Timothy D. McHugh et al. · New England Journal of Medicine · 2014 · 634 citations · Full text

Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

Jotam G. Pasipanodya, Helen McIlleron, A. Burger et al. · The Journal of Infectious Diseases · 2013 · 447 citations · Full text

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani, Thomas S. Harrison, Andrew Nunn et al. · New England Journal of Medicine · 2014 · 436 citations · Full text

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Debra Benator, Mondira Bhattacharya, Lorna Bozeman et al. · The Lancet · 2002 · 408 citations

, , +7